Summary
Ecolab Inc. (ECL) reported fiscal year 2020 sales of $11.8 billion, a decrease of 6% from $12.6 billion in 2019, primarily attributed to the widespread impact of the COVID-19 pandemic. While increased demand for hygiene products in the Healthcare & Life Sciences segment provided a boost, this was more than offset by declines in the Institutional & Specialty, Industrial, and Other segments due to reduced economic activity and mandated restrictions. The company faced a reported net loss of $1.2 billion, or a loss of $4.15 per diluted share, a significant drop from the $1.6 billion net income in the prior year. This was heavily influenced by a substantial net loss from discontinued operations related to the separation of its Upstream Energy business (ChampionX). Excluding special items and discrete tax impacts, adjusted diluted EPS from continuing operations was $4.02, down from $5.12 in 2019, reflecting the challenging operating environment. Despite the headwinds, Ecolab maintained its commitment to returning capital to shareholders, increasing its quarterly dividend by 2% for the 29th consecutive year. The company also continued to invest in its business through strategic acquisitions and emphasized its strong balance sheet and liquidity, with $1.26 billion in cash and cash equivalents at year-end 2020. Management is focused on navigating the pandemic's ongoing effects and positioning the company for long-term growth through innovation and operational efficiency.
Financial Highlights
56 data points| Revenue | $11.79B |
| Cost of Revenue | $6.91B |
| Gross Profit | $4.88B |
| R&D Expenses | $185.00M |
| SG&A Expenses | $3.31B |
| Operating Income | $1.40B |
| Interest Expense | $304.80M |
| Net Income | -$1.21B |
| EPS (Basic) | $-4.20 |
| EPS (Diluted) | $-4.15 |
| Shares Outstanding (Basic) | 287.00M |
| Shares Outstanding (Diluted) | 290.30M |
Key Highlights
- 1In 2020, Ecolab's reported sales decreased by 6% to $11.8 billion, primarily due to the negative impact of the COVID-19 pandemic on key customer segments like hospitality and foodservice.
- 2The company reported a net loss of $1.2 billion ($4.15 per diluted share) in 2020, largely impacted by a $2.17 billion loss from discontinued operations related to the separation of its Upstream Energy business (ChampionX).
- 3Adjusted diluted EPS from continuing operations declined to $4.02 from $5.12 in 2019, reflecting the challenging economic environment.
- 4The company increased its quarterly cash dividend by 2%, marking its 29th consecutive annual dividend increase.
- 5Ecolab maintained a strong balance sheet, with $1.26 billion in cash and cash equivalents at year-end 2020, and ended the year with $6.7 billion in outstanding debt.
- 6Significant special charges and restructuring activities totaling $312 million were recorded in 2020, impacting reported results.
- 7The Global Healthcare & Life Sciences segment showed robust growth, with sales increasing by 21% in 2020, driven by demand for hygiene and disinfection solutions.